EQL Pharma will soon complement its current "nasal swab" Covid-19 antigen test with a saliva-based CE marked self-test for quick detection of a Covid-19 infection. The test is the first CE marked of its kind that can be sold and used by normal consumers rather than healthcare professionals, and EQL has an exclusivity for it on the Nordic market. "We are very proud to be the first company in the Nordics able to offer a more comfortable way of testing yourself and your loved ones for an ongoing Covid-19 infection, without having to first seek the help of a healthcare professional" Axel Schörling concludes. EQL's saliva test will become available in Sweden at the middle of October and EQL have plans to introduce it in the other Nordic countries during the autumn.